全球领先的新经济产业第三方数据挖掘与分析机构
关于“医疗创投”的报告
艾媒咨询|2021年9月中国医疗健康行业投融资数据分析报告
人口老龄化，人均GDP、人均收入的提升，同时也带来了人们健康需求的增长。近年来，医疗健康产业创新不断涌现，并发展成为最活跃的行业之一，相关细分赛道也维持着较高的增长，收获了资本市场的大量关注。
艾媒咨询通过艾媒数据中心(data.iimedia.cn)查询并发布《2021年9月中国医疗健康行业投融资数据分析简报》，助力投资人与创业者用户即时了解市场趋势，获取关键投资决策所需的数据，把握投资逻辑和最新产业机会。(《艾媒咨询|2021年9月中国医疗健康行业投融资数据分析报告》完整高清PDF版共21页，可点击文章底部报告下载按钮进行报告下载)
The aging of population and the increase of per capita GDP and per capita income have also brought about the growth of people's health demand. In recent years, the innovation of medical and health industry has been emerging and developed into one of the most active industries. The relevant segments have also maintained high growth and gained a lot of attention from the capital market.
Iimedia inquires and publishes the analysis briefing on investment and financing data of “China's medical and health industry in September 2021 through iimedia data center (data. Iimedia. cn), so as to help investors and entrepreneurs understand the market trend in real time, obtain the data required for key investment decisions, and grasp the investment logic and the latest industrial opportunities.(“iiMedia Report |Analysis report on investment and financing data of China's medical and health industry in September 2021”full version has 21 pages in total, please click the Browse HD Report button on the right side of the article to browse the report)-
艾媒咨询 | 2025年第四季度全球主要行业投融资数据监测季报
2025年第四季度全球主要行业投融资市场活跃度略有提升但投资热度降温，资金投向呈分散化趋势。根据全球领先的新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2025年第四季度全球主要行业投融资数据监测季报》显示，本季度投资金额为8975.15亿人民币，投资事件数量为2600起。
艾媒咨询分析师认为，投资事件数量增长可能反映市场活跃度有所提升，而投资金额大幅下降或与行业周期调整、政策收紧及市场环境变化有关，例如经济下行压力增大导致投资者趋于谨慎。本季度的特点是，在投资事件增加的背景下，单笔投资规模出现收缩，这可能意味着市场正在重新评估风险。与历史趋势相比，本季度投资金额明显低于上一季度，反映出市场投资热度有所降温，资金投向呈现分散化态势。
In the fourth quarter of 2025, the investment and financing market activity in major global industries slightly increased, but the investment enthusiasm cooled down, and the direction of funds showed a trend of diversification. According to the latest "2025 Fourth Quarter Global Major Industry Investment and Financing Data Monitoring Quarterly Report" released by iiMedia Research (iimedia research), a leading third-party data mining and analysis institution for the new economy industry, the investment amount in this quarter was 897.515 billion RMB, and the number of investment events was 2,600.
Analysts from iiMedia Research believe that the increase in the number of investment events may reflect an improvement in market activity, while the significant decline in investment amount could be related to industry cycle adjustments, tightened policies, and changes in the market environment, such as the increased economic downturn pressure causing investors to become more cautious. The characteristic of this quarter is that, against the backdrop of an increase in investment events, the scale of individual investments has shrunk, which may indicate that the market is reassessing risks. Compared with historical trends, the investment amount in this quarter was significantly lower than that of the previous quarter, reflecting a cooling of investment enthusiasm and a trend of diversified fund allocation. -
-
艾媒咨询 | 2025年11月全球主要行业投融资数据监测月报
2025年11月，全球投融资活跃度和金额均处于较高水平，显示出市场对投融资的持续热情和信心。根据全球领先的新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2025年11月全球主要行业投融资数据监测月报》显示，2025年11月全球投融资金额为3381.87亿人民币，环比上升43.7%；投融资事件数量为902起，环比上升10.1%。艾媒咨询分析师认为，该月数据波动可能受多重因素影响。一是行业周期因素，如年末企业融资需求增强；二是政策推动，尤其是国家对科技创新的扶持政策进一步激发投资动力；三是市场环境改善，全球经济复苏带动整体投资活跃度上升。
In November 2025, both the global investment and financing activity and the amount were at a relatively high level, demonstrating the market's continuous enthusiasm and confidence in investment and financing. According to the latest "Global Major Industry Investment and Financing Data Monitoring Monthly Report" released by iiMedia Research (iimedia research), a leading third-party data mining and analysis institution for the new economy industry, the global investment and financing amount in November 2025 was 338.187 billion RMB, a 43.7% increase compared to the previous month; the number of investment and financing events was 902, a 10.1% increase compared to the previous month. Analysts from iiMedia Research believe that the fluctuations in the data for this month may be influenced by multiple factors. Firstly, industry cycle factors, such as the increased financing needs of enterprises at the end of the year; secondly, policy promotion, especially the national support policies for technological innovation further stimulating investment momentum; thirdly, the improvement of the market environment, with the global economic recovery driving the overall investment activity to rise. -
-
-
-
艾媒咨询|2021年中国医美机构市场竞争态势及企业营销模式分析报告
本报告研究涉及企业/品牌/案例：华韩整形，瑞丽医美，美莱整形，医思健康
数据显示，2016—2020年中国医美行业市场规模五年平均增长率为12.8%，与此同时，中国医美市场用户规模增长了4倍多。在人们生活水平的提升、年轻一代对医美的接受度的提高、政府监管层对医美行业的整治给医美消费者信心的提升的综合作用下，预计中国医美市场规模在2022年将达到2232亿元。随着医美产品及仪器技术水平提升、医美知识普及等，民众对整形美容的观念正在向积极态度转变，在整个行业扩张的过程中，轻医美的受众面广、门槛低、复购率高，更有可能提升市场整体渗透率，成为我国医美行业的主要增量市场。
According to the data, from 2016 to 2020, the five-year average growth rate of the market scale of China's medical and American industry was 12.8%. At the same time, the user scale of China's medical and American market increased by more than four times. Under the combined effect of the improvement of people's living standards, the improvement of the acceptance of medical beauty by the younger generation, the regulation of the medical beauty industry by the government regulators and the improvement of medical beauty consumer confidence, it is expected that the scale of China's medical beauty market will reach 223.2 billion yuan in 2022. With the improvement of the technical level of medical beauty products and instruments and the popularization of medical beauty knowledge, people's concept of plastic beauty is changing to a positive attitude. In the process of the expansion of the whole industry, light medical beauty has a wide audience, low threshold and high repurchase rate, which is more likely to improve the overall penetration rate of the market and become the main incremental market of China's medical beauty industry. -
-
- 1
- 2
- 3
- 4
- 5
- 6
- 75
